Abstract
Objective
To determine the prevalence of R501X mutation of Filaggrin gene in children with allergic diseases.
Methods
Ninety patients recruited from Allergy and Asthma clinic of Advanced Pediatric Centre, PGIMER, Chandigarh and 81 healthy controls from local schools matched for age, gender and BMI were enroled in the present study. The R501X mutation analysis was done by PCR-RFLP method.
Results
Out of the 90 enroled allergic children, 5 (5.5%) were mutant (AA) for R501X genotype, 44 (43.3%) had (AA+Aa) genotype and 46 (51.1%) had (aa) genotype. However, in the control group there were no mutant (AA) for R501X, 36 (44.4%) had (AA+Aa) genotype and 45 had wild type homozygous (aa) genotype. There were 3.3% and 2.2% children with asthma and asthma concomitantly with eczema having mutant R501X genotype.
Conclusions
In the present study, the prevalence of Filaggrin mutant genotype (R501X) was detected in approximately 5.5% of children with allergic diseases.
Similar content being viewed by others
Change history
23 July 2020
There is a small oversight in the abstract of the paper.
References
Johansson SG, Bieber T, Dahl R, et al. Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization. October 2003. J Allergy Clin Immunol. 2004;113:832–6.
Irvine AD, McLean WH, Leung DY. Filaggrin mutations associated with skin and allergic diseases. N Engl J Med. 2011;365:1315–27.
Palmer CN, Irvine AD, Terron-Kwiatkowski A, et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet. 2006;38:441–6.
Brown SJ, McLean WH. One remarkable molecule: filaggrin. J Invest Dermatol. 2011;132:751–62.
Handa S, Khullar G, Pal A, Kamboj P, De D. Filaggrin gene mutations in hand eczema patients in the Indian subcontinent: a prospective case-control study. Contact Dermatitis. 2019. https://doi.org/10.1111/cod.13233.
Marenholz I, Nickel R, Ruschendorf F, et al. Filaggrin loss-of-function mutations predispose to phenotypes involved in the atopic march. J Allergy Clin Immunol. 2006;118:866–71.
Weidinger S, O’Sullivan M, Illig T, et al. Filaggrin mutations, atopic eczema, hay fever, and asthma in children. J Allergy Clin Immunol. 2008;121:1203–9.
Palmer CN, Ismail T, Lee SP, et al. Filaggrin null mutations are associated with increased asthma severity in children and young adults. J Allergy Clin Immunol. 2007;120:64–8.
Rodriguez E, Baurecht H, Herberich E, et al. Meta-analysis of filaggrin polymorphisms in eczema and asthma: robust risk factors in atopic disease. J Allergy Clin Immunol. 2009;123:1361–70.
Henderson J, Northstone K, Lee SP, et al. The burden of disease associated with filaggrin mutations: a population-based, longitudinal birth cohort study. J Allergy Clin Immunol. 2008;121:872–7.
Mildner M, Jin J, Eckhart L, et al. Knockdown of Filaggrin impairs diffusion barrier function and increases UV sensitivity in a human skin model. J Invest Dermatol. 2010;130:2286–94.
Brożek JL, Bousquet J, Agache I, et al. Allergic rhinitis and its impact on asthma (ARIA) guidelines-2016 revision. J Allergy Clin Immunol. 2017;140:950–8.
Rothe MJ, Grant-Kels JM. Diagnostic criteria for atopic dermatitis. Lancet. 1996;348:769–70.
Muller S, Marenholz I, Lee Y-A, et al. Association of Filaggrin loss-of function-mutations with atopic dermatitis and asthma in early treatment of the atopic child (ETAC) population. Pediatr Allergy Immunol. 2009;20:358–61.
O’Regan GM, Sandilands A, McLean WHI, Irvine AD. Filaggrin in atopic dermatitis. J Allergy Clin Immunol. 2008;122:689–93.
De Benedetto A, Qualia CM, Baroody FM, Beck LA. Filaggrin expression in oral, nasal, and esophageal mucosa. J Invest Dermatol. 2008;128:1594–7.
O’Regan GM, Irvine AD. The role of filaggrin in the atopic diathesis. Clin Exp Allergy. 2010;40:965–72.
Akiyama M. FLG mutations in ichthyosis vulgaris and atopic eczema: spectrum of mutations and population genetics. Br J Dermatol. 2010;162:472–7.
Author information
Authors and Affiliations
Contributions
The concept and idea of the study was conceived by AC and MS. Laboratory work was conducted and supported by AC, IP and SVA. The patients were enrolled by AC, MS and IP. The results analyzed and manuscript was written by AC, Ma S and AA. MS is the guarantor for this paper.
Corresponding author
Ethics declarations
Conflict of Interest
None.
Source of Funding
The study was supported by Indian Council of Medical Research, New Delhi through grant no: No 3/1/3/JRF-2010/MOPD-12 (11619).
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Chauhan, A., Panigrahi, I., Singh, M. et al. Prevalence of Filaggrin Gene R501X Mutation in Indian Children with Allergic Diseases. Indian J Pediatr 87, 587–590 (2020). https://doi.org/10.1007/s12098-020-03231-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12098-020-03231-0